FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:217-218 January 21, 1993 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

By Milton Silverman, Mia Lydecker, and Philip R. Lee. 358 pp. Stanford, Calif., Stanford University Press, 1992. $29.95. ISBN 0-8047-1669-2.

Since 1976 Silverman, Lydecker, and Lee have conducted quadrennial surveys that identify the single-drug entities or fixed-drug combinations marketed in North and South America, Africa, Asia, and Europe and describe the manufacturers' indications and warnings. Chapter 2 of their latest book, Bad Medicine, is largely devoted to describing their most recent survey. The actual findings of their survey are presented, in tabular form and without narrative, in the 68-page appendix. The remainder of the monograph is best described as medical journalism.

The book is actually a series of vignettes, based primarily on the authors' personal experiences with, contributions to, and . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.